Healthcare stocks fell Thursday afternoon with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each declining 1%.
The iShares Biotechnology ETF (IBB) shed 0.6%.
In corporate news, Biogen (BIIB) agreed to acquire private biotechnology company RayThera in a deal worth up to $1 billion. Biogen shares fell 2%.